Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer-Reference-Cited by-同舟云学术

Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer

Published:2018-04-01 Issue:4 Volume:4 Page:545
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Sestak Ivana¹,Buus Richard²³,Cuzick Jack¹,Dubsky Peter⁴⁵,Kronenwett Ralf⁶,Denkert Carsten⁷,Ferree Sean⁸,Sgroi Dennis⁹,Schnabel Catherine¹⁰,Baehner Frederick L.¹¹,Mallon Elizabeth¹²,Dowsett Mitch²³

Affiliation:

1. Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, England

2. Ralph Lauren Centre for Breast Cancer Research, Royal Marsden, London, England

3. Breast Cancer Now Research Centre, Institute of Cancer Research, London, England

4. Department of Surgery and Comprehensive Cancer, Medical University of Vienna, Austria

5. Breast Centre, Klinik St Anna, Luzern, Switzerland

6. Sividon Diagnostics, GmbH, Köln, Germany

7. Charité Universitätsmedizin and German Cancer Consortium, Berlin, Germany

8. NanoString Technologies, Seattle, Washington

9. Cancer Center, Massachusetts General Hospital, Boston, Massachusetts

10. Biotheranostics, San Diego, California

11. GenomicHealth, Redwood City, California

12. School of Medicine, Dentistry, and Nursing, University of Glasgow, Glasgow, Scotland

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

http:///jamaoncology/article-pdf/4/4/545/17452095/jamaoncology_sestak_2018_oi_170101.pdf

Reference28 articles.

1. Sorting out breast-cancer gene signatures.;Massagué;N Engl J Med,2007

2. Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.;Harris;J Clin Oncol,2016

3. Clinical use of biomarkers in breast cancer: updated guidelines from the European Group on Tumor Markers (EGTM).;Duffy;Eur J Cancer,2017

4. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.;Coates;Ann Oncol,2015

5. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.;Senkus;Ann Oncol,2015

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images;Breast Cancer Research;2024-08-14

2. Closing the gap: prognostic and predictive biomarker validation for personalized care in a Latin American hormone-dependent breast cancer cohort;The Oncologist;2024-08-08

3. ISMPO Guidelines for Diagnosis and Management of Early Breast Cancer;Indian Journal of Medical and Paediatric Oncology;2024-07-18

4. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-07

5. Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast Cancer;JCO Precision Oncology;2024-07